Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04327466
Other study ID # High frequency highflow
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date May 22, 2020
Est. completion date November 26, 2021

Study information

Verified date January 2022
Source University of Zurich
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study evaluates the effect of non-invasive high frequency oscillations applied via a highflow nasal cannula ('Osciflow') compared to highflow nasal cannula without oscillations (HF) on desaturations and bradycardia in premature infants. It uses a crossover design. Infants are randomized to begin the study with either Osciflow or HF. Both modes are applied for 4 hours. Infants are monitored with an oximetry sensor to measure peripheral oxygen saturation (SpO2) and pulse rate, and with a transcutaneous CO2-transducer. Further measurements include respiratory rate and 'Bernese pain scale' evaluated by nursing staff and Electrical Impedance Tomography (EIT) in a subset of patients.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date November 26, 2021
Est. primary completion date November 26, 2021
Accepts healthy volunteers No
Gender All
Age group N/A and older
Eligibility Inclusion Criteria: - Preterm infants born with a gestational age of <35 weeks - >72 hours old - On nCPAP with PEEP 5 mbar and FiO2 <0.3 Exclusion Criteria: - Severe congenital malformations adversely affecting life expectancy

Study Design


Intervention

Device:
Osciflow
Osciflow is a non-invasive high frequency oscillatory ventilation support delivered via a highflow nasal cannula for four hours (one hour wash-out, three hours measurement period).
Highflow
Standard highflow therapy without oscillations delivered via a highflow nasal cannula for four hours (one hour wash-out, three hours measurement period).

Locations

Country Name City State
Switzerland Department of Neonatology, University Hospital Zurich Zurich

Sponsors (1)

Lead Sponsor Collaborator
University of Zurich

Country where clinical trial is conducted

Switzerland, 

References & Publications (2)

Rub DM, Sivieri EM, Abbasi S, Eichenwald E. Effect of high-frequency oscillation on pressure delivered by high flow nasal cannula in a premature infant lung model. Pediatr Pulmonol. 2019 Nov;54(11):1860-1865. doi: 10.1002/ppul.24459. Epub 2019 Jul 24. — View Citation

Sivieri EM, Eichenwald E, Bakri SM, Abbasi S. Effect of high frequency oscillatory high flow nasal cannula on carbon dioxide clearance in a premature infant lung model: A bench study. Pediatr Pulmonol. 2019 Apr;54(4):436-443. doi: 10.1002/ppul.24216. Epub 2018 Dec 14. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Paired difference in the total number of desaturations and bradycardia between Osciflow and HF 180-minute recording periods for each therapy
Secondary Paired difference in respiratory rate 180-minute recording periods for each therapy
Secondary Paired difference in heart rate 180-minute recording periods for each therapy
Secondary Paired difference in fraction of inspired oxygen [FiO2] 180-minute recording periods for each therapy
Secondary Paired difference in peripheral oxygen saturation [SpO2] 180-minute recording periods for each therapy
Secondary Paired difference in the proportion of time spent with oxygen saturations < 80% 180-minute recording periods for each therapy
Secondary Paired difference in the proportion of time spent with heart rates < 80 bpm 180-minute recording periods for each therapy
Secondary Paired difference in the number of apneas requiring stimulation 180-minute recording periods for each therapy
Secondary Paired difference in transcutaneous CO2 measurements 180-minute recording periods for each therapy
Secondary Paired difference in pain assessment using 'Bernese pain scale' Bernese Pain-Scale for Neonates (BPSN): a 9-item multidimensional pain assessment tool that includes behavioral and physiological indicators. The instrument consists of seven subjective (alertness, crying, consolation, skin color, facial expression, posture, and changes in respiratory rate) and two physiological (i.e. objective) (changes in heart rate and oxygen saturation) indicators. Each item is rated on a four point Likert scale (0, 1, 2, and 3). Higher scores indicate greater pain-related distress, and a total score of 11 or higher is considered to indicate pain. 180-minute recording periods for each therapy
Secondary Paired difference in end-expiratory lung impedance (EELI) in a subset of patients. EELI using electrical impedance tomography (arbitrary units per kilogram). At the end of each intervention period
Secondary Paired difference in regional ventilation distribution in a subset of patients. Regional ventilation distribution using electrical impedance tomography (arbitrary units per kilogram). At the end of each intervention period
Secondary Paired difference in Tidal volumes in a subset of patients. Tidal volumes using electrical impedance tomography (arbitrary units per kilogram). At the end of each intervention period
Secondary Paired difference in nasal trauma score Royal Women's Hospital Nasal Integrity and Pressure Chart.
Nasal injury is defined as stage 0-skin intact; stage 1-nonblanchable erythema of intact skin; stage 2-partial thickness skin loss involving epidermis, dermis, or both; stage 3-full thickness skin loss involving damage to or necrosis of subcutaneous tissue; stage 4-full thickness skin loss with extensive destruction, tissue necrosis, or damage to supporting structures.
Lowest Score: 0. Highest Score: 4. A higher score indicates more extensive nasal injury.
At the end of each intervention period
Secondary Paired difference in the rate of pneumothorax 180-minute recording periods for each therapy
Secondary Paired difference in reaching 'failure criteria' to stop Osciflow or HF therapy: Definition of failure criteria
Respiratory rate >90/min for more than 30 minutes
Respiratory rate >20/min higher than at the beginning of the study
Increase in FiO2 by = 0.25 from baseline for more than 30 minutes
Apnea-Score of more than 20/4 hours
180-minute recording periods for each therapy
See also
  Status Clinical Trial Phase
Recruiting NCT05030337 - Optimising Ventilation in Preterms With Closed-loop Oxygen Control N/A
Completed NCT02916914 - Impact of Feeding Interval of Preterms on the Time of Transition From Tube Feeding to Oral Feeding N/A
Not yet recruiting NCT06335524 - Infant-Maternal Partnership and Cognitive Training Study for Preterm Infants N/A
Completed NCT02391389 - VentFirst Pilot: Ventilating Preterm Infants During Delayed Cord Clamping N/A
Completed NCT00419588 - Growth of Airways and Lung Tissues in Premature and Healthy Infants
Completed NCT05217186 - Associations Between Early Neonatal Neuroimaging, Hammersmith Infant Neurological Examination and General Movements
Completed NCT04886310 - Peabody Developmental Motor Scale-2 in 0 - 24 Months in Turkey
Enrolling by invitation NCT04478487 - Novel Human Milk Based Human Milk Fortifier N/A
Not yet recruiting NCT05592431 - Effect of Volume Guarantee-High Frequency Oscillatory Ventilation on Cerebral Blood Flow in Neonates N/A
Enrolling by invitation NCT05011071 - The Alberta BLOOM Premature Child Study
Completed NCT04889846 - The Effects of SAFE Early Intervention Approach in Premature Infants in Turkey N/A
Recruiting NCT04064398 - Evaluation of Gastric Residuals and Feedings Progression N/A
Completed NCT04500353 - Routine Or Selective Application of a Face Mask for Preterm Infants at Birth: the ROSA Trial N/A
Completed NCT04247308 - Multi Modal Stimulations in Pre-term Neonates N/A
Completed NCT03860142 - Evolution of Food Orality in Children Aged Between 24 and 36 Months: Comparison of the Severity and Specificities of Disorders Between Two Populations of Children, Born Very Prematurely and Born at Term
Completed NCT04234152 - Complete Shielding of Multivitamins to Reduce Toxic Peroxides in the Parenteral Nutrition: A Pilot Study N/A
Terminated NCT04641000 - The Alberta BLOOM Long Term Follow Up Study
Completed NCT04284891 - Critical Respiratory Diseases in Ex-preterm Infants in PICU
Completed NCT00062452 - Esophageal Motility and Airway Defenses Among Infants N/A
Completed NCT00579943 - Regulation of Cerebral Blood Flow in Very Low Birth Weight Infants N/A